Altre lingue Third Harmonic Bio, Inc.

Azioni

THRD

US88427A1079

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 03/05/2024			Variaz. 5gg	Var. 1 gen.
11,7 ^USD	+0,95%		+8,03%	+6,65%

28/03	Third Harmonic Bio, Inc. nomina Geoff McDonough nel suo Consiglio di Amministrazione	CI
26/03	Third Harmonic Bio, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors	28/03
Third Harmonic Bio, Inc. Appoints Geoff Mcdonough to Its Board of Directors	28/03
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results	26/03
Third Harmonic Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference	26/02
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference	26/02
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Third Harmonic Bio, Inc. (NASDAQ: THRD)	22/02
Third Harmonic Bio Names Christopher Murphy as Chief Financial, Business Officer	04/01
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial Officer	04/01
Third Harmonic Bio, Inc. Appoints Christopher Murphy as Chief Business Officer	04/01
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update	04/01
Third Harmonic Bio, Inc.(NasdaqGM:THRD) added to NASDAQ Biotechnology Index	18/12
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Third Harmonic Bio, Inc. (NASDAQ: THRD)	09/11
Third Harmonic Bio Announces Third Quarter 2023 Financial Results	09/11
Third Harmonic Bio Announces Third Quarter 2023 Financial Results	09/11
Third Harmonic Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Third Harmonic Bio Announces Leadership Changes	31/10/23
Third Harmonic Bio, Inc. Announces the Transition of Adrian S. Ray from Chief Scientific Officer to Scientific Advisor, Effective November 1, 2023	31/10/23
Third Harmonic Bio, Inc. Announces Resignation of Robert Ho as Chief Financial Officer, Effective November 10, 2023	31/10/23
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference	31/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Third Harmonic Bio, Inc.

Azioni

THRD

US88427A1079

Altre lingue

Filtri